Skip to main content

Table 1 Characteristics of whole genome scans for linkage for Parkinson's disease

From: Meta analysis of whole-genome linkage scans with data uncertainty: an application to Parkinson's disease

Reference

DeStefanoetal. [11]

Scottetal[9]

Hicksetal[13]

Pankratzetal[10]

Martinezetal[12]

Source Population

US

US

Iceland

US

US + Europe

Diagnostic criteria

UKPDS (adapted)

2 cardinal PD-signs + exclusion criteria

2 cardinal PD-signs + Hoen-Yahr crit.

UPDRS (II+III) Diagnosis Check List

3 cardinal PD-signs or 2 signs and at least 30% improvement with levodpoa treatment no parkin mutations

Family Structure

ASP

multiplex families

multiplex families

multiplex families

multiplex families

No. of Families

113

174

51

325 (170ASP)

199 (227 ASP)

No. of Affected

226

378

117

192

471

No. of Marker

392

344

781

400 SNPs

391

Average distance

11 cM

10 cM

 

8.6 cM

10 cM

Analysis

MLS/NPL

MLOD

Zlr

MLS

MLS

Significant region/markers

9 – D9S1825

5q–D5S816

8p–D8S520

17q – D17S921

1p32–D1S231

D1S2652

2 – D2S206

2p–D2S160

5q–D5S471

6q–D6S257

7p–D7S531

11q–D11S4175

2 – D2S206

19 q – D19S902

  1. *signs compatible with common PD
  2. 1 France, United Kingdom, Netherlands, Germany and Italy
  3. 2 Weber set 8
  4. 3 ABI Prism Linkage Set
  5. ASPaffected sib pair
  6. average
  7. UKPDS UK Parkinson Disease Society Brain Bank Clinical Diagnosis Criteria
  8. UPDRSUnified Parkinson Disease Rating Scale
  9. MLS Maximum Likelihood Score
  10. MLOD Maximum Parametric LOD Score
  11. NPL Nonparametric Linkage Score
  12. Zlr converted LOD score: v [2ln (10)LOD]